Product
PF-07921186
1 clinical trial
3 indications
Indication
Herpes zosterIndication
Herpes ZosterIndication
HumanClinical trial
A PHASE 1/2 RANDOMIZED, OBSERVER-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST VARICELLA ZOSTER VIRUS IN HEALTHY INDIVIDUALSStatus: Recruiting, Estimated PCD: 2025-12-20